Dark

TNXP
Tonix Pharmaceuticals Holding Corp.
stock NASDAQ

At Close

Jul 24, 2026 3:59:55 PM EDT

9.89USD-6.921%(-0.73)715,382

0.00Bid 0.00Ask 0.00Spread

Pre-market

Jul 24, 2026 8:02:30 AM EDT

10.65USD+0.282%(+0.03)162

After-hours

Jul 24, 2026 4:50:30 PM EDT

9.90USD+0.152%(+0.01)157,695

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

157.81M

CEO

Seth Lederman

Headquarters

New York, USA

Industry

Biotechnology

Next Earnings

Aug 10, 2026 (15d)

Last Split

Feb 5, 20251for100reverse

ARQL SUPN PRGO AGRX XLV

TNXP Stats

Avg. Vol. 10 Day

587,088

Avg. Vol. 30 Day

565,387

Employees

Market Cap

157,813,930

Shares Out.

15,940,801

On/Off Exchange

55%/45%

6 Month Beta

2.16

1 Year Beta

2.35

2 Year Beta

1.33

3 Year Beta

1.20

52 Week Low

9.81

52 Week High

69.97

SMA50

12.25

SMA200

15.11

1 Week

-9.84%

1 Month

-25.11%

3 Month

-22.90%

6 Month

-44.85%

1 Year

-80.09%

2 Year

-82.00%

5 Year

-100.00%

Profile

tonix is developing innovative pharmaceutical products to address major public health challenges. in addition to tonmya for ptsd, tonix is developing tnx-601 (tianeptine oxalate), a clinical candidate at pre-ind (investigational new drug) application stage, designed as a daytime treatment for ptsd and tnx-801, a live synthetic version of horsepox virus, at the pre-ind application stage, to be developed as a potential smallpox-preventing vaccine. further information about tonix can be found at www.tonixpharma.com.

TNXP Stock Summary

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) stock price today is $9.89, and today's volume is 715,382. TNXP is down -6.921% today. The 30 day average volume is 565,387. TNXP market cap is 157.81M with 15,940,801 shares outstanding.